- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Insulet Corporation (PODD)
Assess today's live Insulet Corporation (PODD) share price, performance and insights using our live NASDAQ: PODD stock exchange data.
Analyse the historical data and Insulet Corporation share price performance charts on this page. Our technical summary section provides analysis on Insulet share price buy/sell indicators using real-time data (or discuss the Insulet (PODD) stock price today with other investors in the Insulet NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PODD share price (ISIN: US45784P1012) to enhance your trading decisions with our free investment tools and resources.
What Is the Insulet Corporation Share Price Today?
The Insulet share price today is 285.50.
What Is the Stock Symbol for Insulet Corporation
The stock symbol (or 'ticker') for Insulet Corporation is "PODD."
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Insulet Corporation share price performance charts on this page. Our technical summary section provides analysis on Insulet share price buy/sell indicators using real-time data (or discuss the Insulet (PODD) stock price today with other investors in the Insulet NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PODD share price (ISIN: US45784P1012) to enhance your trading decisions with our free investment tools and resources.
What Is the Insulet Corporation Share Price Today?
The Insulet share price today is 285.50.
What Is the Stock Symbol for Insulet Corporation
The stock symbol (or 'ticker') for Insulet Corporation is "PODD."
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
285.02
292.75
52 wk Range
230.05
354.88
PODD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
285.02292.75
52 wk Range
230.05354.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PODD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
377.72
Upside
+32.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Insulet Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Insulet Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Insulet Company Profile
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Insulet Corporation SWOT Analysis
Patch Pump Pionee | Insulet leads the insulin pump market with its innovative Omnipod 5 platform, boasting a $21.58 billion market cap and impressive 70.39% gross margins |
Financial Triumph | Explore Insulet's record-breaking Q1 2025 performance, with 30% worldwide growth and raised 2025 revenue guidance to 19-22%, signaling strong market momentum |
Market Expansion | Delve into Insulet's strategic moves in the Type 2 diabetes market and international expansion, unlocking vast growth potential in underpenetrated segments |
Analyst Optimism | Discover why analysts project bullish price targets ranging from $266 to $365, reflecting confidence in Insulet's technological advancements and market position |
Insulet Corporation Earnings Call Summary for Q3/2025
- Insulet exceeded Q3 2025 expectations with EPS of $1.24 (8.77% above forecast) and revenue of $706.3 million (28% YoY growth), driving a 5.78% pre-market stock increase to $332.61
- Gross margin improved to 72.2% (up 290 basis points YoY) while operating margin reached 17.1%, reflecting successful Omnipod 5 rollout and increased market penetration in both Type 1 and Type 2 diabetes segments
- The company raised its full-year 2025 revenue growth guidance to 28%-29%, with approximately $760 million in cash reserves to support strategic initiatives
- CEO Ashley McEvoy highlighted Insulet's market leadership in automated insulin delivery, while CFO Flavia Pease emphasized strategic investments for long-term growth
- Insulet is preparing for Libre 3 integration in H1 2026, with further strategic details expected at the upcoming November 20th Investor Day
Last Updated: 06/11/2025, 14:56
Read Full TranscriptCompare PODD to Peers and Sector
Metrics to compare | PODD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPODDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 81.6x | 5.3x | −0.6x | |
PEG Ratio | −2.05 | −0.12 | 0.00 | |
Price/Book | 14.5x | 10.4x | 2.6x | |
Price / LTM Sales | 8.0x | 5.7x | 3.2x | |
Upside (Analyst Target) | 33.1% | 17.7% | 41.8% | |
Fair Value Upside | Unlock | −6.2% | 5.1% | Unlock |
Analyst Ratings
24 Buy
2 Hold
0 Sell
Ratings:
26 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 377.72
(+32.30% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
1.24 / 1.14
Revenue / Forecast
706.30M / 678.09M
People Also Watch
FAQ
What Is the Insulet (PODD) Share Price Today?
The live Insulet share price today is 285.50
What Stock Exchange Does Insulet (PODD) Trade On?
Insulet is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Insulet?
The stock symbol (also called a 'ticker') for Insulet is "PODD."
What Is the Current Insulet Market Cap?
As of today, Insulet market capitalisation is 20.08B.
What Is Insulet's (PODD) Earnings Per Share (TTM)?
The Insulet EPS is currently 3.45 (Trailing Twelve Months).
When Is the Next Insulet Earnings Date?
Insulet's next earnings report will be released on 19 Feb 2026.
Is PODD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Insulet moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Insulet Stock Split?
Insulet has split 0 times. (See the PODD stock split history page for full effective split date and price information.)
How Many Employees Does Insulet Have?
Insulet has 3900 employees.
What is the current trading status of Insulet (PODD)?
As of 24 Dec 2025, Insulet (PODD) is trading at a price of 285.50, with a previous close of 291.57. The stock has fluctuated within a day range of 285.02 to 292.75, while its 52-week range spans from 230.05 to 354.88.
What Is Insulet (PODD) Price Target According to Analysts?
The average 12-month price target for Insulet is USD377.72, with a high estimate of USD450 and a low estimate of USD314. 24 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32.30% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.